| Dr Thomas W Fagg, DO | |
|
1002 Lincoln Way, Jefferson, IA 50129 | |
| (515) 386-4192 | |
| (515) 386-3448 |
| Full Name | Dr Thomas W Fagg |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 1002 Lincoln Way, Jefferson, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235127481 | NPI | - | NPPES |
| 0074856 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 02388 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospice Of The Midwest, Llc | Johnston, IA | Hospice |
| Greene County Medical Center | Jefferson, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greene County Medical Center | 0143208595 | 13 |
News Archive
A pair of Montana State University researchers who examine how variations across federally qualified health centers impact efficiency and patient health outcomes - and who are simultaneously working to develop models to better understand the strengths and challenges facing Montana's health care system - have received more than $120,000 to continue their work.
Shionogi & Co., Ltd. announced today that The Lancet Infectious Diseases journal has published clinical results from the pivotal randomized controlled trial evaluating cefiderocol for the treatment of complicated urinary tract infection in patients at risk of multidrug-resistant Gram-negative infections.
A diagnostic test of eight short questions designed by Jaclene Zauszniewski from the Frances Payne Bolton School of Nursing at Case Western Reserve University can be used to detect depressive thinking patterns that lead to clinical depression in women who care for an adult family member with a serious mental illness.
Stem Cell Theranostics announced today that they have successfully completed a research collaboration with Thermo Fisher Scientific focused on advancing the development of cardiac disease models derived from induced pluripotent stem cells using Thermo Fisher Scientific's suite of work flow reagents and SCT's patient biobank and proprietary disease modeling methods.
Amgen Inc. and Centocor Ortho Biotech Products, L.P., today announced that the U.S. Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-stimulating agents (ESAs), which include Aranesp® (darbepoetin alfa), EPOGEN® (Epoetin alfa) and PROCRIT® (Epoetin alfa).
› Verified 3 days ago
| Entity Name | Greene County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245260652 PECOS PAC ID: 0143208595 Enrollment ID: O20040712000717 |
News Archive
A pair of Montana State University researchers who examine how variations across federally qualified health centers impact efficiency and patient health outcomes - and who are simultaneously working to develop models to better understand the strengths and challenges facing Montana's health care system - have received more than $120,000 to continue their work.
Shionogi & Co., Ltd. announced today that The Lancet Infectious Diseases journal has published clinical results from the pivotal randomized controlled trial evaluating cefiderocol for the treatment of complicated urinary tract infection in patients at risk of multidrug-resistant Gram-negative infections.
A diagnostic test of eight short questions designed by Jaclene Zauszniewski from the Frances Payne Bolton School of Nursing at Case Western Reserve University can be used to detect depressive thinking patterns that lead to clinical depression in women who care for an adult family member with a serious mental illness.
Stem Cell Theranostics announced today that they have successfully completed a research collaboration with Thermo Fisher Scientific focused on advancing the development of cardiac disease models derived from induced pluripotent stem cells using Thermo Fisher Scientific's suite of work flow reagents and SCT's patient biobank and proprietary disease modeling methods.
Amgen Inc. and Centocor Ortho Biotech Products, L.P., today announced that the U.S. Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-stimulating agents (ESAs), which include Aranesp® (darbepoetin alfa), EPOGEN® (Epoetin alfa) and PROCRIT® (Epoetin alfa).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas W Fagg, DO 1002 Lincoln Way, Jefferson, IA 50129 Ph: (515) 386-4192 | Dr Thomas W Fagg, DO 1002 Lincoln Way, Jefferson, IA 50129 Ph: (515) 386-4192 |
News Archive
A pair of Montana State University researchers who examine how variations across federally qualified health centers impact efficiency and patient health outcomes - and who are simultaneously working to develop models to better understand the strengths and challenges facing Montana's health care system - have received more than $120,000 to continue their work.
Shionogi & Co., Ltd. announced today that The Lancet Infectious Diseases journal has published clinical results from the pivotal randomized controlled trial evaluating cefiderocol for the treatment of complicated urinary tract infection in patients at risk of multidrug-resistant Gram-negative infections.
A diagnostic test of eight short questions designed by Jaclene Zauszniewski from the Frances Payne Bolton School of Nursing at Case Western Reserve University can be used to detect depressive thinking patterns that lead to clinical depression in women who care for an adult family member with a serious mental illness.
Stem Cell Theranostics announced today that they have successfully completed a research collaboration with Thermo Fisher Scientific focused on advancing the development of cardiac disease models derived from induced pluripotent stem cells using Thermo Fisher Scientific's suite of work flow reagents and SCT's patient biobank and proprietary disease modeling methods.
Amgen Inc. and Centocor Ortho Biotech Products, L.P., today announced that the U.S. Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-stimulating agents (ESAs), which include Aranesp® (darbepoetin alfa), EPOGEN® (Epoetin alfa) and PROCRIT® (Epoetin alfa).
› Verified 3 days ago
Dr. Laurie Lynn Connolly, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1002 Lincoln Way, Jefferson, IA 50129 Phone: 515-386-4192 Fax: 515-386-3448 |